Where to Buy Semax: The Compounding Row Is Empty

Where to buy semax is usually answered with a shortlist of shops, which skips the part that actually decides how the purchase goes. The useful question is what kind of seller you are dealing with, because the type of channel sets what documentation arrives with the vial, what happens if the parcel is stopped, and whether anything is recoverable when the order goes wrong. Those three things differ far more between channels than price does.

It is worth being precise about the compound first, because a lot of pages describing it are describing something else. Semax is a synthetic heptapeptide, seven residues in the order Met-Glu-His-Phe-Pro-Gly-Pro. It is the ACTH(4-7) fragment with a Pro-Gly-Pro tail attached to slow enzymatic breakdown, listed at PubChem CID 9811102 with the formula C37H51N9O10S and a molecular weight of 813.9. If a listing calls it a tuftsin analogue, it has confused it with Selank, a separate Russian heptapeptide with a different sequence and a different mass. The two sit next to each other on most shops and get swapped constantly.

One supplier is linked on this page and we earn a commission if you buy through it, as our affiliate disclosure explains. The comparison below includes the criteria that supplier meets and the one question its paperwork cannot answer.

Start with the closed door, because a surprising number of search results imply it is open. A pharmacy compounding under section 503A of the Federal Food, Drug and Cosmetic Act may work from a bulk drug substance only if one of three conditions holds: the substance complies with a United States Pharmacopeia or National Formulary monograph, or it is a component of an FDA-approved drug product, or it appears on FDA's 503A bulks list. The agency sets out that test on its bulk drug substances page, content current as of 14 May 2026.

Semax fails all three. There is no USP or NF monograph for it. No FDA-approved drug product contains it, because none has ever been approved anywhere in the United States. And it appears on no part of the bulks list.

The third point is where the misinformation concentrates, so here is the precise history. Semax was nominated for the bulks list, was placed in category 2 under FDA's interim policies while the agency evaluated it, and the nomination was then withdrawn. It sits on no current category list at all. Today's category 2 holds six substances, cesium chloride, domperidone, germanium sesquioxide, ibutamoren mesylate, kisspeptin-10 and quinacrine hydrochloride for intrauterine administration, and Semax is not among them. So a page telling you Semax is category 2 is describing a status that ended, and a page telling you it is banned has invented a word the agency did not use. Nominated and withdrawn is the accurate phrase, and for a buyer the practical effect is identical: no pharmacy can lawfully compound it.

That is not true of every peptide sold on the same shelf, which is why the contrast is instructive rather than academic. Our write-up on the compounded prescription route that does exist for NAD+ covers a substance FDA placed in category 1, where the agency has said it does not intend to act against compounders that meet stated conditions. Semax has no equivalent. Any clinic offering to arrange it is operating outside the pharmacy system, whatever its booking page says.

Search where to buy semax peptide rather than the finished product and you land in one of two channels: domestic research-chemical suppliers and overseas chemical marketplaces. Both ship a lyophilised solid. Everything else about them differs.

Domestic research suppliers. A US warehouse lists a sealed vial, usually 10 mg, labelled for laboratory research and not for human consumption. Payment is by card, dispatch is same or next day, and the variable that separates one seller from another is the certificate of analysis. The listing we link is a 10 mg vial at $59.99, or $30.00 with the code PEPTIDEDECK, which works out at $3.00 per milligram. Buying 3, 5 or 10 takes 3 percent, 5 percent or 10 percent off list separately, and free shipping starts at $250. Whether the code and the quantity tiers combine is not documented anywhere we can point to, so do not plan a purchase on the assumption that they do. Figures verified on the listing on 21 August 2026.

Overseas marketplaces. The same powder appears on bulk chemical marketplaces sold by the gram, often at a fraction of the domestic per-milligram cost, because the buyer those listings are built for is a laboratory raising a purchase order. What changes is everything after checkout. A parcel crossing the border meets customs, and FDA's personal importation guidance is explicit that an unapproved drug offered for import may be refused entry. A refused parcel is not a refund. Transit runs to weeks, nobody is temperature controlling anything in a sorting facility, and certificates in this channel are typically supplied on request after payment, frequently for a batch other than the one shipped. Payment by bank transfer ends your recourse the moment it clears.

The other two channels sell something that has already been made into a product, which sounds like an upgrade and is the opposite.

Nootropic retailers selling nasal spray. Semax reaches most consumers as a pre-mixed spray, and that format became the default for this compound largely because it is the form it takes in the country where it holds a registration. What you buy is a solution, meaning someone has already dissolved the peptide, added a carrier or a preservative, filled a bottle, sealed it and assigned it a shelf life. Every one of those is a manufacturing step, and none of these retailers is a drug manufacturer. A certificate for the raw peptide, where one exists at all, says nothing about the sterility, concentration or stability of the liquid in the bottle. The supplier we link sells the lyophilised vial and does not sell a spray, which is worth stating plainly rather than implying otherwise. Our companion piece on what a spray listing has to state for the neighbouring peptide works through the same format problem in detail.

Private resellers. The fourth channel is individuals working through forums, group chats and messaging apps, usually buying bulk from the third channel and repackaging into vials. Repackaging severs the link between the certificate and the vial: whatever testing the original material received described a drum of powder, not the container somebody filled afterwards. This is also where FDA's stated concern about Semax lands hardest. The agency's worry is immunogenicity arising from aggregation and peptide-related impurities, which is a handling and manufacturing problem, and unqualified repackaging is precisely the step that creates those conditions while generating no new documentation. Payment is by peer-to-peer transfer or cryptocurrency, both final by design.

The table sets the five channels against what you receive, what can go wrong and how cost behaves. Only the domestic vial price is a figure we have checked against a live listing. The rest are structural, because the other channels either move prices constantly or do not publish them on a page anyone can open.

Read the middle column as the deciding one. The gap between these channels in price is smaller than the gap in what is recoverable when an order fails, and the cheapest-looking channel is reliably the one where nothing is.

The supplier we link publishes a four-page combined certificate of analysis for batch 30-05260628, and it is worth opening rather than taking our word for. Purity is reported at 99.886 percent against a stated specification of greater than 98 percent. Endotoxin is tested by kinetic chromogenic LAL assay to USP Chapter 85 against an E. coli O111:B4 standard, reporting under 0.20 EU/mL against a 0.5 EU/mL acceptance limit. The microbial sterility screen reports no growth.

That is more than this market usually provides, and it arrived with a batch rather than with a product. The same vendor's own February Semax certificate carries neither an endotoxin test nor a sterility screen, and its Selank listing shows the same February-to-June change. So the thing to check is every certificate on a product page, not only the one that is a clickable link, because the fuller document is often shown as an image while the link still points at the older one. The point of noticing that is not to pick a winner, it is to learn what a complete certificate looks like before you go and read the next seller's.

Now the other half, which a vendor would not write. FDA's position, from its page on bulk drug substances that may present significant safety risks, quoted in full: "Compounded drugs containing semax (heptapeptide) may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities. FDA has no, or limited, safety-related information for proposed routes of administration. Therefore, the agency lacks sufficient information to know whether the drug would cause harm if administered to humans."

Read the two halves together and you can see exactly how far the paperwork reaches. Aggregation and peptide-related impurities are manufacturing problems, and testing is the correct instrument for them, so a batch assayed for purity, checked for identity, screened for endotoxin and showing no growth has addressed a real part of what the agency named. Sellers that skip those tests should not get the same credit. What no certificate does is produce human safety data, and the agency's final sentence is about exactly that. A clean result on batch 30-05260628 means that batch was well made. It says nothing about what the compound does in a person. Both statements are true simultaneously, and any page giving you only one of them is selling you something.

On the evidence, the domestic research supplier with a published, lot-specific certificate wins the comparison, and it wins on a single axis: the volume of checkable evidence attached to the particular vial that arrives at your address. It does not win because it is a good substitute for a prescription, because there is no prescription to substitute for. It wins because it is the only channel where you can read the document before the money moves.

That filter is narrow and it removes most of the market. It removes marketplace listings that supply a certificate for somebody else's batch. It removes resellers who repackage. It removes the tidy-looking shops with a purity figure and no chromatogram behind it. What survives is a vial of research material with paperwork you can check, which is a genuinely different thing from a medicine and should be described that way.

If you want the same treatment applied to the compound Semax is most often confused with, our channel-by-channel guide to buying Selank runs the identical comparison and lands on the same point about reading the batch rather than the brand, which is the whole reason the pairing is useful.